Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hand1
|
ENSMUSG00000037335.7 | heart and neural crest derivatives expressed 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_57836623_57837461 | Hand1 | 4224 | 0.181780 | 0.76 | 3.1e-12 | Click! |
chr11_57833423_57834227 | Hand1 | 1007 | 0.484339 | 0.72 | 5.9e-11 | Click! |
chr11_57827339_57828569 | Hand1 | 4193 | 0.176976 | 0.72 | 1.1e-10 | Click! |
chr11_57828974_57830688 | Hand1 | 2316 | 0.241147 | 0.70 | 5.2e-10 | Click! |
chr11_57832440_57833181 | Hand1 | 8 | 0.972281 | 0.65 | 2.4e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_52231944_52233433 | 7.68 |
Hoxa10 |
homeobox A10 |
636 |
0.35 |
chr3_49753928_49755610 | 7.46 |
Pcdh18 |
protocadherin 18 |
695 |
0.72 |
chr5_119673827_119675890 | 7.24 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr9_56864653_56866648 | 6.84 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
617 |
0.51 |
chr7_142576289_142578620 | 6.65 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr15_27786588_27788615 | 5.96 |
Trio |
triple functional domain (PTPRF interacting) |
1037 |
0.6 |
chr12_33966605_33968831 | 5.48 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
10047 |
0.22 |
chrX_143825863_143827628 | 5.31 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr11_85833878_85836704 | 4.87 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr11_82912320_82912656 | 4.65 |
Unc45b |
unc-45 myosin chaperone B |
1235 |
0.25 |
chr9_58156326_58158409 | 4.48 |
Islr |
immunoglobulin superfamily containing leucine-rich repeat |
1178 |
0.35 |
chr13_15466077_15468087 | 4.36 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr1_163308490_163310681 | 4.33 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr4_41762036_41763125 | 4.30 |
Il11ra1 |
interleukin 11 receptor, alpha chain 1 |
185 |
0.88 |
chr6_52237474_52238484 | 4.27 |
Hoxa10 |
homeobox A10 |
2816 |
0.08 |
chr8_107545084_107547731 | 4.24 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr7_100926314_100930096 | 4.20 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
3902 |
0.17 |
chr8_85364349_85365338 | 4.11 |
Mylk3 |
myosin light chain kinase 3 |
481 |
0.73 |
chr18_75374458_75376171 | 4.01 |
Smad7 |
SMAD family member 7 |
400 |
0.87 |
chr1_170109295_170110836 | 3.95 |
Ddr2 |
discoidin domain receptor family, member 2 |
436 |
0.82 |
chr3_66977838_66980287 | 3.94 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr5_21543417_21545108 | 3.94 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr6_34599135_34600037 | 3.93 |
Cald1 |
caldesmon 1 |
966 |
0.58 |
chr2_74699182_74699450 | 3.85 |
Hoxd9 |
homeobox D9 |
1589 |
0.11 |
chrX_142684757_142686445 | 3.81 |
Tmem164 |
transmembrane protein 164 |
2713 |
0.28 |
chr12_40471563_40472715 | 3.78 |
Dock4 |
dedicator of cytokinesis 4 |
25803 |
0.2 |
chr13_55827549_55829422 | 3.69 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chr11_96251471_96253106 | 3.69 |
Gm53 |
predicted gene 53 |
244 |
0.82 |
chr18_80709509_80710732 | 3.65 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
1947 |
0.3 |
chr15_5869228_5869788 | 3.60 |
Gm8043 |
predicted gene 8043 |
3273 |
0.27 |
chr3_86546255_86547878 | 3.60 |
Lrba |
LPS-responsive beige-like anchor |
311 |
0.85 |
chr12_101817155_101817772 | 3.58 |
Fbln5 |
fibulin 5 |
1005 |
0.56 |
chr17_28348327_28348971 | 3.56 |
Tead3 |
TEA domain family member 3 |
1697 |
0.21 |
chr4_144404354_144405079 | 3.55 |
Pramef12os |
PRAME family member 12, opposite strand |
152 |
0.91 |
chr12_9578132_9580204 | 3.46 |
Osr1 |
odd-skipped related transcription factor 1 |
4727 |
0.2 |
chr18_61663767_61665554 | 3.43 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
830 |
0.45 |
chr2_57997628_57998772 | 3.43 |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
316 |
0.9 |
chr1_162222542_162222984 | 3.41 |
Mir214 |
microRNA 214 |
605 |
0.68 |
chr12_33961784_33963046 | 3.41 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
4744 |
0.25 |
chr13_55825087_55826711 | 3.37 |
Gm47071 |
predicted gene, 47071 |
351 |
0.82 |
chr11_99043636_99045890 | 3.29 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
3 |
0.96 |
chr11_76435834_76437863 | 3.26 |
Abr |
active BCR-related gene |
372 |
0.87 |
chr19_43385959_43387401 | 3.25 |
Hpse2 |
heparanase 2 |
1574 |
0.38 |
chr10_22818712_22820254 | 3.14 |
Tcf21 |
transcription factor 21 |
676 |
0.65 |
chr14_76810574_76811534 | 3.03 |
Gm48968 |
predicted gene, 48968 |
21767 |
0.16 |
chr6_4488753_4490330 | 3.02 |
Gm37883 |
predicted gene, 37883 |
5343 |
0.17 |
chr18_65083730_65084940 | 3.02 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
1281 |
0.54 |
chr11_47377104_47378325 | 2.96 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
1808 |
0.52 |
chr16_25802324_25803670 | 2.95 |
Trp63 |
transformation related protein 63 |
1081 |
0.63 |
chr12_9577276_9578110 | 2.94 |
Osr1 |
odd-skipped related transcription factor 1 |
3252 |
0.23 |
chr13_32518486_32518954 | 2.92 |
Gm48073 |
predicted gene, 48073 |
17695 |
0.24 |
chr3_53043747_53045351 | 2.92 |
Gm42901 |
predicted gene 42901 |
2794 |
0.16 |
chr6_37440238_37440988 | 2.90 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
1533 |
0.51 |
chr8_57326741_57329467 | 2.90 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr13_55962186_55963636 | 2.88 |
Gm47071 |
predicted gene, 47071 |
39354 |
0.14 |
chr9_30920196_30920963 | 2.87 |
Adamts15 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15 |
371 |
0.88 |
chr2_174760566_174761903 | 2.86 |
Edn3 |
endothelin 3 |
182 |
0.96 |
chr5_37967382_37968934 | 2.84 |
Gm40289 |
predicted gene, 40289 |
15535 |
0.2 |
chr6_21989797_21990180 | 2.83 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
3096 |
0.32 |
chr6_52243632_52244238 | 2.81 |
Hoxa11os |
homeobox A11, opposite strand |
458 |
0.51 |
chrX_96456094_96457321 | 2.81 |
Heph |
hephaestin |
279 |
0.62 |
chr5_4754630_4755229 | 2.81 |
Fzd1 |
frizzled class receptor 1 |
3106 |
0.21 |
chr2_172937060_172938226 | 2.80 |
Bmp7 |
bone morphogenetic protein 7 |
2449 |
0.28 |
chr3_101395319_101395945 | 2.79 |
Gm42939 |
predicted gene 42939 |
12161 |
0.14 |
chr1_170108783_170108934 | 2.78 |
Ddr2 |
discoidin domain receptor family, member 2 |
1643 |
0.35 |
chr10_120760564_120761091 | 2.77 |
4921513I03Rik |
RIKEN cDNA 4921513I03 gene |
4905 |
0.14 |
chr2_91035627_91036540 | 2.74 |
Rapsn |
receptor-associated protein of the synapse |
442 |
0.7 |
chr15_50883181_50884101 | 2.74 |
Trps1 |
transcriptional repressor GATA binding 1 |
835 |
0.64 |
chr3_49753055_49753874 | 2.70 |
Pcdh18 |
protocadherin 18 |
2000 |
0.36 |
chr7_99355228_99356541 | 2.66 |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
2645 |
0.21 |
chr6_52224029_52224693 | 2.66 |
Hoxa9 |
homeobox A9 |
1828 |
0.1 |
chr4_133250837_133251842 | 2.65 |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
490 |
0.68 |
chr8_77722901_77723292 | 2.65 |
4933431K23Rik |
RIKEN cDNA 4933431K23 gene |
488 |
0.72 |
chr7_142657905_142658056 | 2.65 |
Igf2 |
insulin-like growth factor 2 |
484 |
0.63 |
chr10_22676116_22676510 | 2.64 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
27305 |
0.14 |
chr17_12636042_12637507 | 2.64 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
15934 |
0.17 |
chr17_88141674_88142030 | 2.61 |
Gm4832 |
predicted gene 4832 |
11137 |
0.17 |
chr13_50958059_50958704 | 2.61 |
Gm19009 |
predicted gene, 19009 |
98225 |
0.07 |
chr8_57320946_57324000 | 2.60 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr11_95121724_95121990 | 2.59 |
Dlx3 |
distal-less homeobox 3 |
1738 |
0.26 |
chr6_52215744_52216574 | 2.58 |
Hoxa7 |
homeobox A7 |
1293 |
0.15 |
chr10_117947298_117947829 | 2.58 |
4933411E08Rik |
RIKEN cDNA 4933411E08 gene |
22104 |
0.16 |
chr10_60828323_60829684 | 2.57 |
Unc5b |
unc-5 netrin receptor B |
2379 |
0.28 |
chr3_84189998_84191469 | 2.54 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr2_180387025_180387876 | 2.51 |
B230312C02Rik |
RIKEN cDNA B230312C02 gene |
1565 |
0.24 |
chr7_16876946_16877218 | 2.51 |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
1765 |
0.16 |
chr8_57324709_57326732 | 2.50 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr11_105293049_105293533 | 2.48 |
Mrc2 |
mannose receptor, C type 2 |
623 |
0.74 |
chr16_14706735_14707615 | 2.48 |
Snai2 |
snail family zinc finger 2 |
1323 |
0.53 |
chr11_28853210_28854208 | 2.47 |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
465 |
0.85 |
chr7_16876015_16876934 | 2.45 |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
1157 |
0.25 |
chr10_97566192_97567945 | 2.45 |
Lum |
lumican |
1940 |
0.32 |
chr8_102783050_102783452 | 2.42 |
Gm45258 |
predicted gene 45258 |
2209 |
0.27 |
chr2_93642502_93643772 | 2.41 |
Alx4 |
aristaless-like homeobox 4 |
749 |
0.73 |
chr11_63131178_63131912 | 2.39 |
Pmp22 |
peripheral myelin protein 22 |
33 |
0.98 |
chr3_129223881_129225649 | 2.37 |
Gm43697 |
predicted gene 43697 |
763 |
0.61 |
chr6_126165403_126167302 | 2.37 |
Ntf3 |
neurotrophin 3 |
363 |
0.92 |
chr7_128003842_128005372 | 2.37 |
Trim72 |
tripartite motif-containing 72 |
229 |
0.69 |
chr2_92023308_92023467 | 2.35 |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
1115 |
0.44 |
chr11_119514733_119515649 | 2.35 |
Endov |
endonuclease V |
13213 |
0.13 |
chr3_99255907_99257438 | 2.35 |
Tbx15 |
T-box 15 |
2912 |
0.22 |
chr8_89036575_89038609 | 2.34 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
chr1_90838238_90839192 | 2.33 |
Gm36970 |
predicted gene, 36970 |
418 |
0.82 |
chr6_99159512_99160517 | 2.33 |
Foxp1 |
forkhead box P1 |
3004 |
0.37 |
chr10_122912675_122913291 | 2.32 |
Ppm1h |
protein phosphatase 1H (PP2C domain containing) |
17615 |
0.2 |
chr11_101892225_101894406 | 2.31 |
Meox1 |
mesenchyme homeobox 1 |
1059 |
0.4 |
chr3_30009457_30010152 | 2.30 |
Mecom |
MDS1 and EVI1 complex locus |
1635 |
0.36 |
chr18_76544225_76544908 | 2.29 |
Gm31933 |
predicted gene, 31933 |
88304 |
0.1 |
chr1_91800905_91802284 | 2.27 |
Twist2 |
twist basic helix-loop-helix transcription factor 2 |
124 |
0.94 |
chr5_137610176_137611504 | 2.26 |
Pcolce |
procollagen C-endopeptidase enhancer protein |
138 |
0.86 |
chr13_53471272_53471968 | 2.26 |
Msx2 |
msh homeobox 2 |
1454 |
0.42 |
chr17_70755180_70756155 | 2.25 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
85 |
0.97 |
chr9_32697004_32697902 | 2.25 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
1069 |
0.51 |
chr16_57550746_57551177 | 2.25 |
Filip1l |
filamin A interacting protein 1-like |
1719 |
0.45 |
chr12_33955777_33956381 | 2.25 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
1592 |
0.42 |
chr2_110361610_110361920 | 2.25 |
Fibin |
fin bud initiation factor homolog (zebrafish) |
1418 |
0.47 |
chr16_26041199_26042258 | 2.24 |
AU015336 |
expressed sequence AU015336 |
460 |
0.86 |
chr1_45312046_45312607 | 2.23 |
Gm47302 |
predicted gene, 47302 |
653 |
0.46 |
chr7_142662290_142664788 | 2.22 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr6_30741945_30743001 | 2.22 |
Mest |
mesoderm specific transcript |
384 |
0.72 |
chr6_141380917_141381972 | 2.22 |
Gm10400 |
predicted gene 10400 |
40891 |
0.17 |
chr15_99818282_99820126 | 2.22 |
Gm17057 |
predicted gene 17057 |
184 |
0.83 |
chr8_11314471_11315722 | 2.22 |
Col4a1 |
collagen, type IV, alpha 1 |
2270 |
0.23 |
chr2_74686971_74688120 | 2.21 |
Gm28309 |
predicted gene 28309 |
4099 |
0.06 |
chr2_73263358_73264974 | 2.20 |
Sp9 |
trans-acting transcription factor 9 |
7759 |
0.16 |
chr4_154238534_154239219 | 2.18 |
Megf6 |
multiple EGF-like-domains 6 |
1351 |
0.38 |
chr1_135837715_135838209 | 2.18 |
Tnnt2 |
troponin T2, cardiac |
1549 |
0.29 |
chr14_46941266_46942395 | 2.17 |
Mir378c |
microRNA 378c |
13098 |
0.12 |
chr6_5392013_5392545 | 2.16 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
1852 |
0.43 |
chr5_75148315_75152589 | 2.16 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr17_23682713_23684127 | 2.16 |
Cldn9 |
claudin 9 |
606 |
0.42 |
chr10_44454467_44455437 | 2.15 |
Prdm1 |
PR domain containing 1, with ZNF domain |
2258 |
0.31 |
chr4_137471203_137471685 | 2.14 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
2641 |
0.2 |
chr4_33289178_33290195 | 2.13 |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
477 |
0.79 |
chr7_16892200_16892882 | 2.12 |
Gng8 |
guanine nucleotide binding protein (G protein), gamma 8 |
220 |
0.83 |
chr11_102606785_102607497 | 2.11 |
Fzd2 |
frizzled class receptor 2 |
2745 |
0.14 |
chr6_87334089_87334818 | 2.11 |
Gm44414 |
predicted gene, 44414 |
407 |
0.69 |
chr11_104318691_104319872 | 2.11 |
Mapt |
microtubule-associated protein tau |
1248 |
0.44 |
chr6_21985465_21987128 | 2.09 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
300 |
0.93 |
chr9_32637137_32637513 | 2.09 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
1077 |
0.46 |
chr9_79717097_79719307 | 2.09 |
Col12a1 |
collagen, type XII, alpha 1 |
292 |
0.9 |
chr8_47134944_47136227 | 2.09 |
E330018M18Rik |
RIKEN cDNA E330018M18 gene |
66 |
0.98 |
chr17_12766020_12767485 | 2.08 |
Igf2r |
insulin-like growth factor 2 receptor |
2912 |
0.17 |
chr16_14708705_14709220 | 2.08 |
Snai2 |
snail family zinc finger 2 |
3110 |
0.32 |
chr7_112825291_112826896 | 2.07 |
Tead1 |
TEA domain family member 1 |
13541 |
0.24 |
chr2_155943427_155945506 | 2.06 |
Gdf5 |
growth differentiation factor 5 |
901 |
0.42 |
chr11_55417729_55419811 | 2.06 |
Sparc |
secreted acidic cysteine rich glycoprotein |
1128 |
0.44 |
chr6_21822751_21823961 | 2.06 |
Tspan12 |
tetraspanin 12 |
28472 |
0.16 |
chr4_137473013_137474569 | 2.05 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
4988 |
0.15 |
chr10_124288216_124288691 | 2.05 |
Gm47837 |
predicted gene, 47837 |
69591 |
0.14 |
chr19_43888532_43890580 | 2.04 |
Dnmbp |
dynamin binding protein |
1135 |
0.42 |
chr1_162223270_162223824 | 2.04 |
Mir214 |
microRNA 214 |
179 |
0.94 |
chr3_104788742_104790202 | 2.04 |
Rhoc |
ras homolog family member C |
244 |
0.84 |
chr5_99191049_99191845 | 2.03 |
Gm43251 |
predicted gene 43251 |
20026 |
0.21 |
chr10_125970130_125970976 | 2.03 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4300 |
0.33 |
chr6_72676953_72678018 | 2.03 |
Tcf7l1 |
transcription factor 7 like 1 (T cell specific, HMG box) |
6081 |
0.11 |
chr8_121118797_121121438 | 2.02 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr2_180388160_180389480 | 2.02 |
Mir1a-1 |
microRNA 1a-1 |
228 |
0.89 |
chr7_6727103_6728704 | 2.02 |
Peg3 |
paternally expressed 3 |
2516 |
0.14 |
chr5_119680221_119681643 | 2.02 |
Tbx3 |
T-box 3 |
683 |
0.62 |
chr11_98939306_98940520 | 2.02 |
Rara |
retinoic acid receptor, alpha |
201 |
0.89 |
chr2_35557994_35559313 | 2.01 |
Gm13446 |
predicted gene 13446 |
49 |
0.85 |
chr10_22815720_22817074 | 2.01 |
Gm10824 |
predicted gene 10824 |
648 |
0.66 |
chr3_68467947_68469189 | 2.01 |
Schip1 |
schwannomin interacting protein 1 |
385 |
0.89 |
chr5_119834833_119836185 | 2.00 |
Tbx5 |
T-box 5 |
646 |
0.68 |
chr10_103026340_103027824 | 2.00 |
Alx1 |
ALX homeobox 1 |
1545 |
0.39 |
chr7_27367427_27368339 | 2.00 |
Gm20479 |
predicted gene 20479 |
10464 |
0.1 |
chr1_192850833_192852651 | 2.00 |
Sertad4 |
SERTA domain containing 4 |
5 |
0.96 |
chr15_35298298_35298499 | 2.00 |
Osr2 |
odd-skipped related 2 |
1902 |
0.34 |
chr9_50751156_50752468 | 1.99 |
Cryab |
crystallin, alpha B |
65 |
0.86 |
chr5_113799288_113800716 | 1.99 |
Tmem119 |
transmembrane protein 119 |
444 |
0.69 |
chr18_61663030_61663726 | 1.98 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
2112 |
0.18 |
chr7_24499513_24500150 | 1.98 |
Cadm4 |
cell adhesion molecule 4 |
130 |
0.91 |
chr3_129199938_129200611 | 1.98 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
305 |
0.89 |
chr2_33641457_33645822 | 1.98 |
C130021I20Rik |
Riken cDNA C130021I20 gene |
2308 |
0.22 |
chr8_48482577_48482783 | 1.98 |
Tenm3 |
teneurin transmembrane protein 3 |
72633 |
0.12 |
chr13_51412096_51412399 | 1.98 |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
3608 |
0.23 |
chr10_125328072_125328912 | 1.98 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
43 |
0.98 |
chr2_92140355_92141595 | 1.96 |
Phf21a |
PHD finger protein 21A |
43131 |
0.11 |
chr3_104790520_104791322 | 1.96 |
Rhoc |
ras homolog family member C |
1062 |
0.32 |
chr3_126363591_126364889 | 1.96 |
Arsj |
arylsulfatase J |
556 |
0.8 |
chr13_114966293_114966735 | 1.95 |
Gm47776 |
predicted gene, 47776 |
31446 |
0.17 |
chr4_120813989_120815034 | 1.95 |
Nfyc |
nuclear transcription factor-Y gamma |
1201 |
0.36 |
chr4_41760125_41761587 | 1.95 |
Il11ra1 |
interleukin 11 receptor, alpha chain 1 |
344 |
0.75 |
chr4_14621039_14622190 | 1.95 |
Slc26a7 |
solute carrier family 26, member 7 |
55 |
0.99 |
chr4_134315034_134315974 | 1.94 |
Trim63 |
tripartite motif-containing 63 |
292 |
0.83 |
chr16_25804796_25805376 | 1.92 |
Trp63 |
transformation related protein 63 |
3170 |
0.34 |
chr3_5089996_5090891 | 1.92 |
Gm17308 |
predicted gene, 17308 |
167 |
0.97 |
chr10_63457257_63458786 | 1.92 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr1_171252040_171252819 | 1.92 |
Adamts4 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4 |
313 |
0.68 |
chr19_30624408_30625607 | 1.92 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
484 |
0.86 |
chr5_119804344_119805024 | 1.92 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
2983 |
0.24 |
chr11_59138835_59139238 | 1.92 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
134 |
0.94 |
chr6_100704458_100705765 | 1.92 |
Gxylt2 |
glucoside xylosyltransferase 2 |
356 |
0.85 |
chr3_81038821_81039521 | 1.91 |
Gm16000 |
predicted gene 16000 |
1266 |
0.36 |
chr8_102781834_102782440 | 1.91 |
Gm45258 |
predicted gene 45258 |
1095 |
0.5 |
chr13_72365680_72366590 | 1.91 |
Gm47836 |
predicted gene, 47836 |
5512 |
0.23 |
chr5_113796469_113797793 | 1.91 |
Tmem119 |
transmembrane protein 119 |
3315 |
0.13 |
chr1_170109106_170109260 | 1.91 |
Ddr2 |
discoidin domain receptor family, member 2 |
1318 |
0.42 |
chr5_98029380_98029719 | 1.91 |
Antxr2 |
anthrax toxin receptor 2 |
1413 |
0.32 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 16.2 | GO:0003166 | bundle of His development(GO:0003166) |
2.8 | 8.4 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.7 | 10.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
2.2 | 6.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.9 | 7.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.8 | 5.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.8 | 1.8 | GO:0060513 | prostatic bud formation(GO:0060513) |
1.8 | 5.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.8 | 5.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.7 | 3.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.7 | 6.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.7 | 3.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.6 | 3.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.6 | 4.7 | GO:0070384 | Harderian gland development(GO:0070384) |
1.5 | 1.5 | GO:0010159 | specification of organ position(GO:0010159) |
1.5 | 15.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.5 | 3.0 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.5 | 1.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.5 | 4.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.4 | 2.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.4 | 2.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.4 | 2.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.4 | 4.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.3 | 8.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.3 | 4.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.3 | 2.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.2 | 2.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 1.2 | GO:0060435 | bronchiole development(GO:0060435) |
1.2 | 2.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.1 | 4.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.1 | 8.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.1 | 3.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.1 | 1.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.1 | 1.1 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
1.1 | 4.2 | GO:0030035 | microspike assembly(GO:0030035) |
1.1 | 4.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.1 | 3.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.0 | 10.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.0 | 3.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 3.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.0 | 3.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.0 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 2.8 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.9 | 1.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.9 | 19.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.9 | 2.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.9 | 6.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.9 | 6.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 3.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.9 | 3.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.9 | 2.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 1.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.9 | 9.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.9 | 2.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.9 | 2.7 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.9 | 1.7 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.9 | 1.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.9 | 4.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 2.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.8 | 2.5 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.8 | 0.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.8 | 0.8 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.8 | 3.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.8 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 2.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 1.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.8 | 1.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.8 | 2.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.8 | 0.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.8 | 2.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 2.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.8 | 1.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.8 | 0.8 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.8 | 1.5 | GO:0007494 | midgut development(GO:0007494) |
0.7 | 2.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.7 | 3.0 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.7 | 3.7 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.7 | 2.2 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.7 | 4.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.7 | 3.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 3.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.7 | 3.4 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 0.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 2.1 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.7 | 0.7 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.7 | 2.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 6.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.7 | 1.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 2.0 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 5.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.7 | 1.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.7 | 2.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.7 | 2.0 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.7 | 2.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 0.6 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.6 | 3.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.6 | 1.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.6 | 4.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.6 | 2.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 2.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.6 | 6.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.6 | 3.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 1.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.6 | 1.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 4.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 3.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 0.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 2.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.6 | 1.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 1.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.6 | 1.7 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 1.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.6 | 1.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 1.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.6 | 10.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 2.8 | GO:0030578 | PML body organization(GO:0030578) |
0.6 | 4.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 0.5 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.5 | 2.7 | GO:0035989 | tendon development(GO:0035989) |
0.5 | 4.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 0.5 | GO:0002339 | B cell selection(GO:0002339) |
0.5 | 2.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 8.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 1.6 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.5 | 2.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 1.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 6.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.5 | 1.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.5 | 1.0 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.5 | 3.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.5 | 2.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.5 | 1.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.5 | 0.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 6.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.5 | 3.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.5 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.5 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.5 | 1.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 2.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 5.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 3.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 2.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 3.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 1.3 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 1.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 0.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.4 | 0.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 0.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 1.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 1.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 4.8 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.4 | 0.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 0.4 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.4 | 1.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 2.4 | GO:0060068 | vagina development(GO:0060068) |
0.4 | 0.8 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.4 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 0.8 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 2.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.4 | 1.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.4 | 1.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.4 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 1.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.4 | 1.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 2.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 1.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 1.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.7 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.4 | 1.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 3.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 0.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.7 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 2.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 1.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 21.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 2.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 7.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.3 | 0.7 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 0.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.3 | 0.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.3 | 1.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 2.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 1.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 0.9 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.3 | 1.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.3 | 1.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 0.9 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 0.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 1.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 1.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 0.9 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 0.3 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.3 | 0.3 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.3 | 1.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.8 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 1.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 1.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 1.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 4.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 1.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 0.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.8 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 0.8 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 0.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 0.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.3 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.3 | 1.0 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 0.8 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 1.2 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.7 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.2 | 2.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.5 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 1.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 1.2 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 2.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 1.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.7 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.2 | 4.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.9 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.2 | 1.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.9 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 1.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.2 | 0.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.2 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 1.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.4 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.2 | 0.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.0 | GO:0043584 | nose development(GO:0043584) |
0.2 | 0.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 1.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 1.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.2 | GO:0071725 | response to bacterial lipoprotein(GO:0032493) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 1.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.8 | GO:0032196 | transposition(GO:0032196) |
0.2 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 4.3 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 0.7 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 2.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 1.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.5 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 2.5 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 5.8 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.2 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 1.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.5 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.2 | 0.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 0.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 4.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.9 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.8 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.2 | 0.3 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 1.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.5 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 1.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.5 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 0.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 1.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 1.0 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.2 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 2.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.3 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.9 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 1.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 2.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.6 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 2.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.6 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.4 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.9 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.3 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.1 | 0.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 1.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.8 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.1 | 0.4 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.9 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.5 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 1.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.7 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 1.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 4.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 2.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 1.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.5 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 1.3 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.5 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.6 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 1.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 1.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.8 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 1.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.1 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.1 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 1.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 1.1 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 2.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 1.9 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 2.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.8 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 1.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.2 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0061428 | peptidyl-aspartic acid modification(GO:0018197) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.4 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 1.3 | GO:0051216 | cartilage development(GO:0051216) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.1 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.2 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.2 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
0.1 | 0.6 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.5 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.3 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.1 | 0.2 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.1 | 0.3 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.2 | GO:0035510 | DNA dealkylation(GO:0035510) DNA demethylation(GO:0080111) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.3 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.5 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 1.1 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 1.7 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.0 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.0 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.3 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.7 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.3 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.0 | 0.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.5 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.0 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0061448 | connective tissue development(GO:0061448) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.4 | 5.6 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 3.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.2 | 4.7 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 3.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.0 | 11.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.9 | 2.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.9 | 5.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.9 | 3.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 3.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 9.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 2.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.7 | 5.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.7 | 5.4 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 3.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.6 | 3.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 9.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 7.2 | GO:0043034 | costamere(GO:0043034) |
0.5 | 5.0 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.3 | GO:0044393 | microspike(GO:0044393) |
0.4 | 0.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 2.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 0.8 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 1.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 3.1 | GO:0043256 | laminin complex(GO:0043256) |
0.4 | 3.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 5.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 2.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 2.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 5.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 2.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 8.4 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 3.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 3.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 82.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 13.2 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 11.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 2.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 7.4 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 41.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 3.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 3.1 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 8.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 2.6 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 6.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 2.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.1 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 3.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 34.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 2.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 2.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 2.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.7 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 1.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.0 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 7.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.6 | 12.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 9.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.4 | 6.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.2 | 3.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.1 | 7.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.0 | 3.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.0 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 3.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.9 | 9.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 3.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.8 | 2.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.8 | 5.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.8 | 4.1 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 4.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.8 | 2.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 0.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 4.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 3.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.7 | 2.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 6.4 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 1.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.6 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 3.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 3.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.6 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 1.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 1.7 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 1.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 2.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 4.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 6.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.5 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 3.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 3.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 2.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 1.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 1.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.5 | 3.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 1.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 2.3 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 1.8 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 1.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 1.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 0.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 2.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 2.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 5.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 7.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 2.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 2.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 2.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 3.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 1.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 3.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 1.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.7 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 4.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 1.0 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 2.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 3.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 3.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 33.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 2.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 3.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 4.0 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 3.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 5.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 3.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 3.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 8.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 3.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 1.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 3.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 6.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 1.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.6 | GO:0034922 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.2 | 3.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.1 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 0.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 1.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 3.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 18.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 7.5 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 1.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 1.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 2.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 1.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 3.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 3.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 4.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.3 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.2 | 11.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 2.9 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.3 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 2.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 2.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 27.8 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 1.9 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 4.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 5.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 2.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 4.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 7.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 6.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 2.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 6.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 2.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.3 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 2.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.3 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 3.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.6 | GO:0034805 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 1.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 2.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0034823 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 34.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.7 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 2.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 4.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 2.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.2 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 2.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 4.8 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0018638 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 4.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.4 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 30.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 16.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 14.8 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 3.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 11.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 3.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 1.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 6.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 1.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 11.8 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 5.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 7.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 7.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 4.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 5.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 15.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 10.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 1.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 33.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 6.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 3.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 4.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 3.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 5.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 6.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 1.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 4.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 6.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 4.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 28.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 4.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 23.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 7.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.0 | 14.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 6.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 35.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 13.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 14.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 11.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 5.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 5.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 0.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.5 | 0.9 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 1.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 7.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.4 | 4.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 1.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 4.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 5.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 2.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 3.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 5.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 2.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 11.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 1.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 5.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 9.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 3.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.9 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |